VXL:CA Vaxil Bio Ltd

CAD 0.02 0.00 0
Icon

Vaxil Bio Ltd (VXL:CA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | TSV
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

CAD 0.015

0.00 (0.00)%

CAD 2.05M

0.05M

N/A

N/A

Icon

VXL:CA

Vaxil Bio Ltd (CAD)
COMMON STOCK | TSV
CAD 0.02
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

CAD 2.05M

N/A

CAD 0.02

Vaxil Bio Ltd (VXL:CA) Stock Forecast

N/A

Based on the Vaxil Bio Ltd stock forecast from 0 analysts, the average analyst target price for Vaxil Bio Ltd is not available over the next 12 months. Vaxil Bio Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Vaxil Bio Ltd is Bearish, which is based on 1 positive signals and 4 negative signals. At the last closing, Vaxil Bio Ltd’s stock price was CAD 0.015. Vaxil Bio Ltd’s stock price has changed by +0.00% over the past week, +50.00% over the past month and -25.00% over the last year.

No recent analyst target price found for Vaxil Bio Ltd
No recent average analyst rating found for Vaxil Bio Ltd

Company Overview Vaxil Bio Ltd

Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company's lead product is ImMucin that has completed a Phase I/II clinical trial for the treatment of multiple myel...Read More

https://www.vaxil-bio.com

3400 One First Canadian Place, Toronto, ON, Canada, M5X 1A4

0

December

CAD

Canada

Adjusted Closing Price for Vaxil Bio Ltd (VXL:CA)

Loading...

Unadjusted Closing Price for Vaxil Bio Ltd (VXL:CA)

Loading...

Share Trading Volume for Vaxil Bio Ltd Shares

Loading...

Compare Performance of Vaxil Bio Ltd Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for VXL:CA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Vaxil Bio Ltd (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NGEN:CA
NervGen Pharma Corp -0.10 (-4.48%) CAD0.16B N/A -6.97

ETFs Containing VXL:CA

Symbol Name VXL:CA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Vaxil Bio Ltd (VXL:CA) Stock

Stock Target Advisor's fundamental analysis for Vaxil Bio Ltd's stock is Bearish.

Unfortunately we do not have enough data on VXL:CA's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on VXL:CA's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on VXL:CA's stock to indicate if its overvalued.

The last closing price of VXL:CA's stock was CAD 0.02.

The most recent market capitalization for VXL:CA is CAD 2.05M.

Unfortunately we do not have enough analyst data on VXL:CA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Vaxil Bio Ltd's stock.

As per our most recent records Vaxil Bio Ltd has 0 Employees.

Vaxil Bio Ltd's registered address is 3400 One First Canadian Place, Toronto, ON, Canada, M5X 1A4. You can get more information about it from Vaxil Bio Ltd's website at https://www.vaxil-bio.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...